← All stories
Markets
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
– Appointed Michael Halstead, former President of Intra-Cellular Therapies, as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization – – Completed enrollment in the Phase 3 APPROACH pivotal study…
Covered by 1 outlet
All coverage · 1 article